Tag: Regeneron Pharmaceuticals
-
U.K Court Rules in Favor of Genentech in Parent Dispute
A U.K court has ruled that a drug manufactured by Regeneron Pharmaceuticals and Bayer to treat wet age-related macular degeneration breaches a European patent owned by Genentech, according Bloomberg in a wire report published online yesterday afternoon. According to the Bloomberg article, Tarrytown, New York-based Regeneron and Leverkusen, Germany-based Bayer had wanted the court not […]